DE69025023D1 - Peptide und deren Benutzung - Google Patents

Peptide und deren Benutzung

Info

Publication number
DE69025023D1
DE69025023D1 DE69025023T DE69025023T DE69025023D1 DE 69025023 D1 DE69025023 D1 DE 69025023D1 DE 69025023 T DE69025023 T DE 69025023T DE 69025023 T DE69025023 T DE 69025023T DE 69025023 D1 DE69025023 D1 DE 69025023D1
Authority
DE
Germany
Prior art keywords
peptide
adult
antibody
associated antigen
cell leukemia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69025023T
Other languages
English (en)
Other versions
DE69025023T2 (de
Inventor
Yoshiaki Maeda
Hiroshi Shiraki
Yukiko Washitani
Naotaka Kuroda
Kyoko Yamada
Kiichiro Oka
Toshihiko Namba
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kuraray Co Ltd
Original Assignee
Kuraray Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kuraray Co Ltd filed Critical Kuraray Co Ltd
Application granted granted Critical
Publication of DE69025023D1 publication Critical patent/DE69025023D1/de
Publication of DE69025023T2 publication Critical patent/DE69025023T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57426—Specifically defined cancers leukemia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
    • C12N2740/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69025023T 1989-10-13 1990-10-12 Peptide und deren Benutzung Expired - Fee Related DE69025023T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1266983A JP2807287B2 (ja) 1989-10-13 1989-10-13 ペプチドおよびその用途

Publications (2)

Publication Number Publication Date
DE69025023D1 true DE69025023D1 (de) 1996-03-07
DE69025023T2 DE69025023T2 (de) 1996-08-22

Family

ID=17438426

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69025023T Expired - Fee Related DE69025023T2 (de) 1989-10-13 1990-10-12 Peptide und deren Benutzung

Country Status (5)

Country Link
US (1) US5194586A (de)
EP (1) EP0423649B1 (de)
JP (1) JP2807287B2 (de)
AT (1) ATE133422T1 (de)
DE (1) DE69025023T2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681696A (en) * 1987-01-09 1997-10-28 United Biomedical, Inc. Synthetic peptide compositions with immunoreactivities to antibodies to HTLV
EP0551308A4 (en) * 1990-08-29 1994-09-14 Us Health Novel peptide antigens and immunoassays, test kits and vaccines using the same
US5652211A (en) * 1991-02-11 1997-07-29 Biosynth S.R.L. Peptides for neutralizing the toxicity of Lipid A
SE9202318L (sv) * 1992-08-10 1994-02-11 Replico Medical Ab Nya peptider, diagnostiska antigen, användning därav, vacciner och medikamenter
CZ295838B6 (cs) * 1996-09-09 2005-11-16 Zealand Pharma A/S Způsob výroby peptidů
EP1950223A3 (de) * 1998-03-09 2009-05-13 Zealand Pharma A/S Pharmakologisch aktive Peptidkonjugate mit verringerter enzymatischer Hydrolysetendenz
US20040223966A1 (en) * 2002-10-25 2004-11-11 Wolfman Neil M. ActRIIB fusion polypeptides and uses therefor
GB0703175D0 (en) * 2007-02-20 2007-03-28 Ge Healthcare Bio Sciences Ab Polymeric device suitable for ultraviolet detection

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2182667B1 (de) * 1972-05-03 1978-03-03 Rhone Poulenc Ind
DE3380564D1 (en) * 1982-09-30 1989-10-19 Japan Found Cancer Human leukemia virus-related peptides, antibodies of the peptides and a process for production of the antibodies
JPS62500452A (ja) * 1984-09-19 1987-02-26 ザ　リ−ジエンツ　オブ　ザ　ユニバ−シテイ　オブ　カリフオルニア ヒト細胞形質転換に関連するレトロウイルスポリペプチド
US4629783A (en) * 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
AU1366088A (en) * 1987-01-28 1988-08-24 Ortho Pharmaceutical Corporation Immunosuppressive peptides and methods of use
SE467542B (sv) * 1989-06-13 1992-08-03 Syntello Ab Syntetiska peptidantigener, immuniserande komposition och immunanalys foer htlv-1 antikroppar

Also Published As

Publication number Publication date
JPH03127799A (ja) 1991-05-30
US5194586A (en) 1993-03-16
JP2807287B2 (ja) 1998-10-08
ATE133422T1 (de) 1996-02-15
DE69025023T2 (de) 1996-08-22
EP0423649B1 (de) 1996-01-24
EP0423649A1 (de) 1991-04-24

Similar Documents

Publication Publication Date Title
ATE320448T1 (de) Gereinigte primate clta-8 antigene und verwandte reagenzien
EP0458841A4 (en) Method for the use and synthesis of peptides
BR9106220A (pt) Antigenos sinteticos para a deterccao de anticorpos para o virus da hepatite c.
ATE71411T1 (de) Monoklonale antikoerper mit spezifitaet fuer membran-assoziierte antigene.
AU640699B2 (en) Carrier for binding antiphospholipid antibody, immunoassay using the same, and kit therefor
DE69025023D1 (de) Peptide und deren Benutzung
FI925321A (fi) Immunodiagnostiskt ledinflammationstest
ATE133993T1 (de) Protein-antikrebsmittel
ATE147406T1 (de) Synthetisches cdw52(campath-1) peptidantigen
EP0404935A4 (en) Synthetic peptide compositions with immunoreactivities to antibodies to htlv-1
AU3825389A (en) Hcg peptides for use in antibody purification procedures
JPS6488367A (en) Immobilized antibody
ES2109225T3 (es) Anticuerpos, su produccion y uso.
NZ215143A (en) Immunoassay and test kit for aids
DE69233666D1 (de) Verzweigte Peptide zum Nachweis von Antikörpern
EP0443880A3 (en) Assay for equine infectious anemia virus
RU97109300A (ru) Иммуносорбент для обнаружения антител к ядерному белку вируса гепатита с в сыворотке крови

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee